{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Predictors of Metastases in Rectal Neuroendocrine Tumors: Results of a National Cohort Study

Activity Steps


Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Describe the characteristics of rectal neuroendocrine tumors that are more likely to develop distant metastatic disease.
  2. Discuss how the differentiation of rectal neuroendocrine tumors impacts the likelihood of metastasis.
  3. Outline the optimal therapy of rectal neuroendocrine tumors based on the size of the tumor
Price: $10.00


  • ACCME 1.5 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: DCR1218
Published: December 2018
Expires: 11/11/2020
Required Passing Score: 4/6 (66%)
Authors: Seth J. Concors, M.D., Andrew J. Sinnamon, M.D., MSCE, Ian W. Folkert, M.D., Najjia N. Mahmoud, M.D., Douglas L. Fraker, M.D., E. Carter Paulson, M.D., MSCE, Robert E. Roses, M.D.
Topics: Chronic Illness